Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 831


The Over Time Conditional Survival of Intravesical Recurrence in Upper Tract Urothelial Carcinoma.

Shigeta K, Kikuchi E, Hagiwara M, Ando T, Mizuno R, Abe T, Mikami S, Miyajima A, Nakagawa K, Oya M.

J Urol. 2017 Jun 17. pii: S0022-5347(17)74909-9. doi: 10.1016/j.juro.2017.06.073. [Epub ahead of print]


Renal hemorrhage caused by acquired inhibitors to coagulation factors VIII and V in a hemodialysis patient.

Niwa N, Yoshida T, Mizuno R, Oya M, Hayashi M.

CEN Case Rep. 2016 Nov;5(2):223-226. doi: 10.1007/s13730-016-0229-y. Epub 2016 Jul 25.


Prognostic significance of erythrocyte protein band 4.1-like5 expression in upper urinary tract urothelial carcinoma.

Daimon T, Kosaka T, Kikuchi E, Mikami S, Miyazaki Y, Hashimoto A, Hashimoto S, Mizuno R, Miyajima A, Okada Y, Sabe H, Oya M.

Urol Oncol. 2017 May 5. pii: S1078-1439(17)30177-1. doi: 10.1016/j.urolonc.2017.04.008. [Epub ahead of print]


Continuous thermographic observation may predict extravasation in chemotherapy-treated patients.

Oya M, Murayama R, Oe M, Yabunaka K, Tanabe H, Takahashi T, Matsui Y, Otomo E, Komiyama C, Sanada H.

Eur J Oncol Nurs. 2017 Jun;28:56-61. doi: 10.1016/j.ejon.2017.02.009. Epub 2017 Mar 25.


Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study.

Tomita Y, Fukasawa S, Shinohara N, Kitamura H, Oya M, Eto M, Tanabe K, Kimura G, Yonese J, Yao M, Motzer RJ, Uemura H, McHenry MB, Berghorn E, Ozono S.

Jpn J Clin Oncol. 2017 Apr 13:1-8. doi: 10.1093/jjco/hyx049. [Epub ahead of print]


Headache Caused by Brain Metastases of Castration-resistant Prostate Cancer during Cabazitaxel Therapy.

Watanabe K, Kosaka T, Hongo H, Tamaki S, Oya M.

Keio J Med. 2017 Apr 7. doi: 10.2302/kjm.2016-0014-CR. [Epub ahead of print]


Modified Measles.

Oya M, Hakozaki Y, Kubota T.

Intern Med. 2017;56(7):885. doi: 10.2169/internalmedicine.56.7639. Epub 2017 Apr 1. No abstract available.


Prolonged pneumoperitoneum time is an independent risk factor for intravesical recurrence after laparoscopic radical nephroureterectomy in upper tract urothelial carcinoma.

Shigeta K, Kikuchi E, Hagiwara M, Ando T, Mizuno R, Miyajima A, Nakagawa K, Oya M.

Surg Oncol. 2017 Mar;26(1):73-79. doi: 10.1016/j.suronc.2017.01.003. Epub 2017 Jan 23.


Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients.

Mikami S, Oya M, Kosaka T, Mizuno R, Miyazaki Y, Sato Y, Okada Y.

Lab Invest. 2017 Mar 13. doi: 10.1038/labinvest.2017.26. [Epub ahead of print]


Overall survival of first-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II study.

Oya M, Tomita Y, Fukasawa S, Shinohara N, Habuchi T, Rini BI, Fujii Y, Kamei Y, Umeyama Y, Bair AH, Uemura H.

Cancer Sci. 2017 Jun;108(6):1231-1239. doi: 10.1111/cas.13232. Epub 2017 May 22.


Obstructive sleep apnea syndrome should be considered as a cause of nocturia in younger patients without other voiding symptoms.

Maeda T, Fukunaga K, Nagata H, Haraguchi M, Kikuchi E, Miyajima A, Yamasawa W, Shirahama R, Narita M, Betsuyaku T, Asano K, Oya M.

Can Urol Assoc J. 2016 Jul-Aug;10(7-8):E241-E245. doi: 10.5489/cuaj.3508. Epub 2016 Jul 12.


Diagnosis of Renal Angiomyolipomas: Classic, Fat-Poor, and Epithelioid Types.

Jinzaki M, Silverman SG, Akita H, Mikami S, Oya M.

Semin Ultrasound CT MR. 2017 Feb;38(1):37-46. doi: 10.1053/j.sult.2016.11.001. Epub 2016 Nov 5.


Simple and practical nomograms for predicting the stone-free rate after shock wave lithotripsy in patients with a solitary upper ureteral stone.

Niwa N, Matsumoto K, Miyahara M, Omura M, Kobayashi H, Kikuchi E, Miyajima A, Miyata K, Oya M.

World J Urol. 2017 Feb 20. doi: 10.1007/s00345-017-2014-8. [Epub ahead of print]


Impact of baseline visceral fat accumulation on prognosis in patients with metastatic renal cell carcinoma treated with systemic therapy.

Mizuno R, Miyajima A, Hibi T, Masuda A, Shinojima T, Kikuchi E, Jinzaki M, Oya M.

Med Oncol. 2017 Apr;34(4):47. doi: 10.1007/s12032-017-0908-3. Epub 2017 Feb 17.


Natural course of asymptomatic abnormal prostate findings incidentally detected by CT after intravesical BCG therapy.

Matsushima M, Kikuchi E, Akita H, Miyajima A, Oya M, Jinzaki M.

Int J Clin Oncol. 2017 Jun;22(3):554-562. doi: 10.1007/s10147-017-1096-z. Epub 2017 Feb 10.


Characterizing intermediate-risk non-muscle-invasive bladder cancer: Implications for the definition of intermediate risk and treatment strategy.

Matsumoto K, Kikuchi E, Yanai Y, Hayakawa N, Ito Y, Maeda T, Nagata H, Miyajima A, Oya M.

Urol Oncol. 2017 May;35(5):208-214. doi: 10.1016/j.urolonc.2016.11.014. Epub 2017 Jan 3.


Influence of physician years on urological journal publication productivity among Japanese urologists.

Niwa N, Kikuchi E, Matsumoto K, Miyajima A, Oya M.

Springerplus. 2016 Nov 29;5(1):2040. eCollection 2016.


Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk model.

Tanaka N, Mizuno R, Yasumizu Y, Ito K, Shirotake S, Masunaga A, Ito Y, Miyazaki Y, Hagiwara M, Kanao K, Mikami S, Nakagawa K, Momma T, Masuda T, Asano T, Oyama M, Oya M.

Urol Oncol. 2017 Feb;35(2):39.e19-39.e28. doi: 10.1016/j.urolonc.2016.10.001. Epub 2016 Nov 4.


Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation.

Tanaka N, Kosaka T, Miyazaki Y, Mikami S, Niwa N, Otsuka Y, Minamishima YA, Mizuno R, Kikuchi E, Miyajima A, Sabe H, Okada Y, Uhlén P, Suematsu M, Oya M.

JCI Insight. 2016 Nov 3;1(18):e83654.


Cellular automaton simulation of the diffusive motion of bacteria and their adhesion to nanostructures on a solid surface.

Yamamoto T, Emura C, Oya M.

Comput Biol Med. 2016 Dec 1;79:173-181. doi: 10.1016/j.compbiomed.2016.10.017. Epub 2016 Oct 17.


Supplemental Content

Support Center